| Literature DB >> 27818347 |
Ulrike Kogel1, Bjoern Titz1, Walter K Schlage2, Catherine Nury1, Florian Martin1, Alberto Oviedo3, Stefan Lebrun1, Ashraf Elamin1, Emmanuel Guedj1, Keyur Trivedi1, Nikolai V Ivanov1, Patrick Vanscheeuwijck1, Manuel C Peitsch1, Julia Hoeng4.
Abstract
Modified risk tobacco products (MRTPs) are being developed with the aim of reducing smoking-related health risks. The Tobacco Heating System 2.2 (THS2.2) is a candidate MRTP that uses the heat-not-burn principle. Here, systems toxicology approaches were engaged to assess the respiratory effects of mentholated THS2.2 (THS2.2M) in a 90-day rat inhalation study (OECD test guideline 413). The standard endpoints were complemented by transcriptomics and quantitative proteomics analyses of respiratory nasal epithelium and lung tissue and by lipidomics analysis of lung tissue. The adaptive response of the respiratory nasal epithelium to conventional cigarette smoke (CS) included squamous cell metaplasia and an inflammatory response, with high correspondence between the molecular and histopathological results. In contrast to CS exposure, the adaptive tissue and molecular changes to THS2.2M aerosol exposure were much weaker and were limited mostly to the highest THS2.2M concentration in female rats. In the lung, CS exposure induced an inflammatory response, triggered cellular stress responses, and affected sphingolipid metabolism. These responses were not observed or were much lower after THS2.2M aerosol exposure. Overall, this system toxicology analysis complements and reconfirms the results from classical toxicological endpoints and further suggests potentially reduced health risks of THS2.2M.Entities:
Keywords: Lipidomics; Modified risk tobacco product; Proteomics; Subchronic inhalation toxicity; Systems toxicology; Transcriptomics
Mesh:
Substances:
Year: 2016 PMID: 27818347 DOI: 10.1016/j.yrtph.2016.11.001
Source DB: PubMed Journal: Regul Toxicol Pharmacol ISSN: 0273-2300 Impact factor: 3.271